Suppression of cytokine-inducible nitric oxide synthesis during intraperitoneal Meth A tumor growth

Oh-Deog Kwon1, Chang-Yeol Yim, Kyu-Shik Jeong

  • 1University of Utah Cancer Immunotherapy Program, Department of Internal Medicine of the University of Utah School of Medicine, Salt Lake City, 84132, USA.

Insights

Nitric oxide (NO) synthesis decreases during Meth A fibrosarcoma tumor progression. This suppression may stem from essential co-factor depletion impacting inducible nitric oxide synthase (iNOS) function.

Area of Science:

  • Immunology
  • Cancer Biology
  • Biochemistry

Background:

  • Nitric oxide (NO) synthesis is upregulated in various tumors.
  • Understanding NO's role in tumor progression is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the temporal dynamics of NO synthesis during Meth A fibrosarcoma progression.
  • To identify factors contributing to altered NO production in the tumor microenvironment.

Main Methods:

  • Monitoring macrophage recruitment and inducible nitric oxide synthase (iNOS) activity in ascites.
  • Assessing cellular responsiveness to lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma).
  • Utilizing electron paramagnetic resonance spectroscopy and nitrotyrosine immunostaining.

Main Results:

  • iNOS antigen and function peaked between days 3-6 post-implantation, followed by a decline.
  • Cellular response to LPS and IFN-gamma was significantly impaired by day 9.
  • Cellular proliferation showed an inverse correlation with NO synthesis levels.
  • No characteristic NO-induced target cell lesions were detected.

Conclusions:

  • NO production is progressively suppressed during Meth A tumor progression.
  • This suppression is not directly linked to inhibitory cytokines TGF-beta and IL-10.
  • Sepiapterin supplementation partially restored NO production, suggesting co-factor depletion (tetrahydrobiopterin) as a contributing factor.

Related Concept Videos